George E. Durán

2.4k total citations
54 papers, 1.7k citations indexed

About

George E. Durán is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, George E. Durán has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Molecular Biology and 11 papers in Cell Biology. Recurrent topics in George E. Durán's work include Drug Transport and Resistance Mechanisms (16 papers), Microtubule and mitosis dynamics (11 papers) and Cancer therapeutics and mechanisms (8 papers). George E. Durán is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Microtubule and mitosis dynamics (11 papers) and Cancer therapeutics and mechanisms (8 papers). George E. Durán collaborates with scholars based in United States, France and Germany. George E. Durán's co-authors include Branimir I. Šikić, Kevin G. Chen, Charles Dumontet, Yan C. Wang, Lidija Beketić-Orešković, Dejan Juric, Anamaria Brozović, Norman J. Lacayo, Ron Yu and Carla Washington and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

George E. Durán

53 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
George E. Durán	958	860	263	227	172	54	1.7k
Michelle J. Henderson	1.6k 1.7×	1.1k 1.3×	442 1.7×	151 0.7×	118 0.7×	40	2.5k
Leonard Lothstein	978 1.0×	890 1.0×	164 0.6×	187 0.8×	83 0.5×	37	1.6k
François Moreau‐Gaudry	1.8k 1.9×	460 0.5×	295 1.1×	100 0.4×	96 0.6×	79	2.7k
Douglas C. Marchion	1.8k 1.8×	609 0.7×	253 1.0×	104 0.5×	47 0.3×	66	2.3k
Rita Humeniuk	818 0.9×	647 0.8×	541 2.1×	63 0.3×	247 1.4×	31	1.8k
Wendy Schober	1.8k 1.9×	729 0.8×	355 1.3×	142 0.6×	116 0.7×	64	3.0k
James J. Starling	1.1k 1.2×	1.3k 1.5×	103 0.4×	67 0.3×	239 1.4×	55	2.2k
Franklin C. Harwood	919 1.0×	547 0.6×	144 0.5×	45 0.2×	94 0.5×	17	1.4k
Hanan Galski	1.0k 1.1×	1.2k 1.4×	85 0.3×	75 0.3×	167 1.0×	30	1.9k
Michael Saborowski	968 1.0×	1.1k 1.3×	362 1.4×	68 0.3×	42 0.2×	26	2.1k

Countries citing papers authored by George E. Durán

Since Specialization

Citations

This map shows the geographic impact of George E. Durán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Durán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Durán more than expected).

Fields of papers citing papers by George E. Durán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George E. Durán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Durán. The network helps show where George E. Durán may publish in the future.

Co-authorship network of co-authors of George E. Durán

This figure shows the co-authorship network connecting the top 25 collaborators of George E. Durán. A scholar is included among the top collaborators of George E. Durán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George E. Durán. George E. Durán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hosoya, Hitomi, Brian J. Sworder, Bita Sahaf, et al.. (2025). Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma. Nature Communications. 16(1). 1824–1824. 2 indexed citations

Hosoya, Hitomi, Sebastian Fernandez‐Pol, John Gubatan, et al.. (2025). Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine. Blood. 147(11). 1191–1198.

Durán, George E., Sebastian Fernandez‐Pol, Shufeng Li, et al.. (2024). Genetic alteration of class I HLA in cutaneous T-cell lymphoma. Blood. 145(3). 311–324. 1 indexed citations

Tadić, Vanja, George E. Durán, Sanja Dabelić, et al.. (2023). Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer. Cellular and Molecular Life Sciences. 80(10). 294–294. 10 indexed citations

Beygi, Sara, George E. Durán, Sebastian Fernandez‐Pol, et al.. (2022). Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma. Blood. 139(26). 3732–3736. 23 indexed citations

Durán, George E. & Branimir I. Šikić. (2019). The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance. PLoS ONE. 14(1). e0210879–e0210879. 3 indexed citations

Durán, George E., Volker Derdau, Dietmar Weitz, et al.. (2018). Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein. Cancer Chemotherapy and Pharmacology. 81(6). 1095–1103. 35 indexed citations

Durán, George E., et al.. (2017). Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition. British Journal of Cancer. 116(10). 1318–1328. 42 indexed citations

Brozović, Anamaria, et al.. (2015). The miR‐200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR‐3 and MES‐OV cells. Molecular Oncology. 9(8). 1678–1693. 75 indexed citations

10.

Durán, George E., Yan C. Wang, John C. Rose, et al.. (2014). Mechanisms of Resistance to Cabazitaxel. Molecular Cancer Therapeutics. 14(1). 193–201. 78 indexed citations

11.

Brozović, Anamaria, George E. Durán, Yan C. Wang, et al.. (2014). Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers. Molecular Oncology. 8(7). 1231–1239. 97 indexed citations

12.

Chen, Kevin G., Yan C. Wang, Marci E. Schaner, et al.. (2005). Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. Cancer Research. 65(20). 9388–9397. 41 indexed citations

13.

Lacayo, Norman J., George E. Durán, & Branimir I. Šikić. (2003). Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug‐resistant cells. PubMed. 3(3). 127–135. 7 indexed citations

14.

Chen, Kevin G., Norman J. Lacayo, George E. Durán, et al.. (2002). Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug‐resistant variants of a human sarcoma. Genes Chromosomes and Cancer. 34(4). 372–383. 20 indexed citations

15.

Chen, Kevin G., George E. Durán, Alexandra Mangili, Lidija Beketić-Orešković, & Branimir I. Šikić. (2000). MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. British Journal of Cancer. 83(7). 892–898. 32 indexed citations

16.

Dumontet, Charles, W. Brent Derry, George E. Durán, et al.. (1995). Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833.. PubMed. 7(10-11). 517–27. 74 indexed citations

17.

Beketić-Orešković, Lidija, George E. Durán, Kevin G. Chen, Charles Dumontet, & Branimir I. Šikić. (1995). Decreased Mutation Rate for Cellular Resistance to Doxorubicin and Suppression of mdrl Gene Activation by the Cyclosporin PSC 833. JNCI Journal of the National Cancer Institute. 87(21). 1593–1602. 64 indexed citations

18.

Jaffrézou, Jean‐Pierre, Kevin G. Chen, George E. Durán, et al.. (1995). Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1266(1). 1–8. 52 indexed citations

19.

Jaffrézou, J P, Kevin G. Chen, George E. Durán, J. Kühl, & Branimir I. Šikić. (1994). Mutation Rates and Mechanisms of Resistance to Etoposide Determined From Flucattion Analysis. JNCI Journal of the National Cancer Institute. 86(15). 1152–1158. 28 indexed citations

20.

Lewis, Alexander D., George E. Durán, Derick Lau, & Branimir I. Šikić. (1992). Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism. International Journal of Radiation Oncology*Biology*Physics. 22(4). 821–824. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact